Abstract
Reversible phosphorylation is arguably the best understood, if not the most important mechanism a cell employs to dynamically regulate protein (and thereby cellular) activity. In recent years the field of proteomics has acquired an impressive tool kit with which to study protein phosphorylation on a more global scale. These tools build upon classical techniques and incorporate novel methodologies, all propelled by rapid advances in mass spectrometers that function with increased speed, sensitivity and resolution. The depth and breadth of phosphoproteomic analyses are becoming increasingly comprehensive from both cumulative and single-study perspectives. Phosphoproteomics is now poised to become increasingly functional as experimental design incorporates the amassed wealth of current biological understanding with novel technologies and quantitative mass spectrometry. In this chapter, three important phosphoproteomic sample preparation methodologies are described: classical phospho-dependent affinity chromatography, tandem strong cation exchange-immobilized metal affinity chromatography (SCX-IMAC), and immunoaffinity chromatography. Each method is discussed with an eye toward designing experiments that maximize phospho-dependent functional understanding.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AQUA:
-
Absolute Quantification
- ApoER2:
-
ApoE Receptor 2
- ATP:
-
Adenosine Triphosphate
- ATM:
-
Ataxia-Telangiectasia Mutated
- ATR:
-
Ataxia-Telangiectasia Mutated and Rad3-Related
- BRCT:
-
Breast Cancer 1 C-terminal
- CST:
-
Cell Signaling Technology
- Crk:
-
CT10-Regulator of Kinase
- CrkL:
-
CT10-Regulator of Kinase-Like
- Dab1:
-
Disabled-1
- FHA:
-
Forkhead-Associated
- GST:
-
Glutathione-S Transferase
- IMAC:
-
Immobilized Metal Affinity Chromatography
- LC:
-
Liquid Chromatography
- MH2:
-
Mother Against Decapentaplegic Homology 2
- MS:
-
Mass Spectrometry
- PhPO4 :
-
Phenyl Phosphate
- PI 3-K:
-
Phosphoinositide 3-Kinase
- PLC:
-
Phospholipase C
- PTB:
-
Phosphotyrosine-Binding
- pY-Dab1:
-
Phosphotyrosyl-Disabled-1
- PTM:
-
Posttranslational Modification
- RTK:
-
Receptor Tyrosine Kinase
- RSK:
-
90 Kilodalton Ribosomal S6 Kinase
- Sf9:
-
Spodoptera frugiperda-9
- SFK:
-
Src Family Tyrosine Kinase
- SDS-PAGE:
-
Sodium Dodecyl Dulfate Polyacrylamide Gel Electrophoresis
- SH2:
-
Src Homology 2
- SCX:
-
Strong Cation Exchange Chromatography
- TCA:
-
Trichloroacetic Acid
- VLDLR:
-
Very Low Density Lipoprotein Receptor
References
Anjum, R., Roux, P.P., Ballif, B.A., Gygi, S.P., and Blenis, J. (2005). The tumor suppressor DAP kinase is a target of RSK-mediated survival signaling. Curr Biol 15, 1762–1767.
Arnaud, L., Ballif, B.A., Forster, E., and Cooper, J.A. (2003). Fyn tyrosine kinase is a critical regulator of disabled-1 during brain development. Curr Biol 13, 9–17.
Ballif, B.A., Arnaud, L., Arthur, W.T., Guris, D., Imamoto, A., and Cooper, J.A. (2004). Activation of a Dab1/CrkL/C3G/Rap1 pathway in reelin-stimulated neurons. Curr Biol 14, 606–610.
Ballif, B.A., Arnaud, L., and Cooper, J.A. (2003). Tyrosine phosphorylation of disabled-1 is essential for reelin-stimulated activation of akt and Src family kinases. Brain Res Mol Brain Res 117, 152–159.
Ballif, B.A., Cao, Z., Schwartz, D., Carraway, K.L., 3rd., and Gygi, S.P. (2006). Identification of 14-3-3epsilon substrates from embryonic murine brain. J Proteome Res 5, 2372–2379.
Ballif, B.A., Carey, G.R., Sunyaev, S.R., and Gygi, S.P. (2008). Large-scale identification and evolution indexing of tyrosine phosphorylation sites from murine brain. J Proteome Res 7, 311–318.
Ballif, B.A., Roux, P.P., Gerber, S.A., MacKeigan, J.P., Blenis, J., and Gygi, S.P. (2005). Quantitative phosphorylation profiling of the ERK/p90 ribosomal S6 kinase-signaling cassette and its targets, the tuberous sclerosis tumor suppressors. Proc Natl Acad Sci USA 102, 667–672.
Beausoleil, S.A., Villen, J., Gerber, S.A., Rush, J., and Gygi, S.P. (2006). A probability-based approach for high-throughput protein phosphorylation analysis and site localization. Nat Biotechnol 24, 1285–1292.
Benzinger, A., Muster, N., Koch, H.B., Yates, J.R., 3rd., and Hermeking, H. (2005). Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. Mol Cell Proteomics 4, 785–795.
Berezin, I.V., Levashov, A.V., and Martinek, K. (1970). On the modes of interaction between competitive inhibitors and the alpha-chymotrypsin active centre. FEBS Lett 7, 20–22.
Boersema, P.J., Foong, L.Y., Ding, V.M., Lemeer, S., van Breukelen, B., Philp, R., Boekhorst, J., Snel, B., den Hertog, J., Choo, A.B., et al. (2009). In depth qualitative and quantitative profiling of tyrosine phosphorylation using a combination of phosphopeptide immuno-affinity purification and stable isotope dimethyl labeling. Mol Cell Proteomics 9, 84–99.
Cortez, D., Glick, G., and Elledge, S.J. (2004). Minichromosome maintenance proteins are direct targets of the ATM and ATR checkpoint kinases. Proc Natl Acad Sci USA 101, 10078–10083.
de la Fuente van Bentem, S., Mentzen, W.I., de la Fuente, A., and Hirt, H. (2008). Towards functional phosphoproteomics by mapping differential phosphorylation events in signaling networks. Proteomics 8, 4453–4465.
Dengjel, J., Kratchmarova, I., and Blagoev, B. (2009). Receptor tyrosine kinase signaling: A view from quantitative proteomics. Mol Biosyst 5, 1112–1121.
Druker, B.J., Mamon, H.J., and Roberts, T.M. (1989). Oncogenes, growth factors, and signal transduction. N Engl J Med 321, 1383–1391.
Elia, A.E., Rellos, P., Haire, L.F., Chao, J.W., Ivins, F.J., Hoepker, K., Mohammad, D., Cantley, L.C., Smerdon, S.J., and Yaffe, M.B. (2003). The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain. Cell 115, 83–95.
Elias, J.E., and Gygi, S.P. (2007). Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat Methods 4, 207–214.
Feng, L., and Cooper, J.A. (2009). Dual functions of Dab1 during brain development. Mol Cell Biol 29, 324–332.
Forrest, A.R., Taylor, D.F., Fink, J.L., Gongora, M.M., Flegg, C., Teasdale, R.D., Suzuki, H., Kanamori, M., Kai, C., Hayashizaki, Y., et al. (2006). PhosphoregDB: The tissue and sub-cellular distribution of mammalian protein kinases and phosphatases. BMC Bioinformatics 7, 82.
Gerber, S.A., Kettenbach, A.N., Rush, J., and Gygi, S.P. (2007). The absolute quantification strategy: Application to phosphorylation profiling of human separase serine 1126. Methods Mol Biol 359, 71–86.
Gerber, S.A., Rush, J., Stemman, O., Kirschner, M.W., and Gygi, S.P. (2003). Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc Natl Acad Sci USA 100, 6940–6945.
Herrick, T.M., and Cooper, J.A. (2002). A hypomorphic allele of dab1 reveals regional differences in reelin-Dab1 signaling during brain development. Development 129, 787–796.
Hiesberger, T., Trommsdorff, M., Howell, B.W., Goffinet, A., Mumby, M.C., Cooper, J.A., and Herz, J. (1999). Direct binding of reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 24, 481–489.
Howell, B.W., Gertler, F.B., and Cooper, J.A. (1997a). Mouse disabled (mDab1): A src binding protein implicated in neuronal development. EMBO J 16, 121–132.
Howell, B.W., Hawkes, R., Soriano, P., and Cooper, J.A. (1997b). Neuronal position in the developing brain is regulated by mouse disabled-1. Nature 389, 733–737.
Howell, B.W., Herrick, T.M., Hildebrand, J.D., Zhang, Y., and Cooper, J.A. (2000). Dab1 tyrosine phosphorylation sites relay positional signals during mouse brain development. Curr Biol 10, 877–885.
Hunter, T., and Plowman, G.D. (1997). The protein kinases of budding yeast: Six score and more. Trends Biochem Sci 22, 18–22.
Jin, J., Smith, F.D., Stark, C., Wells, C.D., Fawcett, J.P., Kulkarni, S., Metalnikov, P., O’Donnell, P., Taylor, P., Taylor, L., et al. (2004). Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr Biol 14, 1436–1450.
Johnson, S.A., and Hunter, T. (2005). Kinomics: Methods for deciphering the kinome. Nat Methods 2, 17–25.
Krebs, E.G., and Fischer, E.H. (1956). The phosphorylase b to a converting enzyme of rabbit skeletal muscle. Biochim Biophys Acta 20, 150–157.
Kuo, G., Arnaud, L., Kronstad-O’Brien, P., and Cooper, J.A. (2005). Absence of fyn and src causes a reeler-like phenotype. J Neurosci 25, 8578–8586.
Lemeer, S., and Heck, A.J. (2009). The phosphoproteomics data explosion. Curr Opin Chem Biol 13, 414–420.
Luo, W., Slebos, R.J., Hill, S., Li, M., Brabek, J., Amanchy, R., Chaerkady, R., Pandey, A., Ham, A.J., and Hanks, S.K. (2008). Global impact of oncogenic src on a phosphotyrosine proteome. J Proteome Res 7, 3447–3460.
Macek, B., Mann, M., and Olsen, J.V. (2009). Global and site-specific quantitative phosphoproteomics: Principles and applications. Annu Rev Pharmacol Toxicol 49, 199–221.
Manning, G., Plowman, G.D., Hunter, T., and Sudarsanam, S. (2002a). Evolution of protein kinase signaling from yeast to man. Trends Biochem Sci 27, 514–520.
Manning, G., Whyte, D.B., Martinez, R., Hunter, T., and Sudarsanam, S. (2002b). The protein kinase complement of the human genome. Science 298, 1912–1934.
Matsuoka, S., Ballif, B.A., Smogorzewska, A., McDonald, E.R., 3rd., Hurov, K.E., Luo, J., Bakalarski, C.E., Zhao, Z., Solimini, N., Lerenthal, Y., et al. (2007). ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316, 1160–1166.
Meek, S.E., Lane, W.S., and Piwnica-Worms, H. (2004). Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. J Biol Chem 279, 32046–32054.
Mohammad, D.H., and Yaffe, M.B. (2009). 14-3-3 proteins, FHA domains and BRCT domains in the DNA damage response. DNA Repair (Amst) 8, 1009–1017.
Nita-Lazar, A., Saito-Benz, H., and White, F.M. (2008). Quantitative phosphoproteomics by mass spectrometry: Past, present, and future. Proteomics 8, 4433–4443.
Obenauer, J.C., Cantley, L.C., and Yaffe, M.B. (2003). Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res 31, 3635–3641.
Olsen, J.V., Ong, S.E., and Mann, M. (2004). Trypsin cleaves exclusively C-terminal to arginine and lysine residues. Mol Cell Proteomics 3, 608–614.
Ong, S.E., Blagoev, B., Kratchmarova, I., Kristensen, D.B., Steen, H., Pandey, A., and Mann, M. (2002). Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1, 376–386.
Park, T.J., and Curran, T. (2008). Crk and crk-like play essential overlapping roles downstream of disabled-1 in the reelin pathway. J Neurosci 28, 13551–13562.
Pawson, T., and Kofler, M. (2009). Kinome signaling through regulated protein-protein interactions in normal and cancer cells. Curr Opin Cell Biol 21, 147–153.
Pawson, T., and Scott, J.D. (2005). Protein phosphorylation in signaling–50 years and counting. Trends Biochem Sci 30, 286–290.
Phizicky, E.M., and Fields, S. (1995). Protein-protein interactions: Methods for detection and analysis. Microbiol Rev 59, 94–123.
Rappsilber, J., Ishihama, Y., and Mann, M. (2003). Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal Chem 75, 663–670.
Rice, D.S., Sheldon, M., D’Arcangelo, G., Nakajima, K., Goldowitz, D., and Curran, T. (1998). Disabled-1 acts downstream of reelin in a signaling pathway that controls laminar organization in the mammalian brain. Development 125, 3719–3729.
Rikova, K., Guo, A., Zeng, Q., Possemato, A., Yu, J., Haack, H., Nardone, J., Lee, K., Reeves, C., Li, Y., et al. (2007). Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 131, 1190–1203.
Rogers, L.D., and Foster, L.J. (2009). Phosphoproteomics–finally fulfilling the promise? Mol Biosyst 5, 1122–1129.
Roux, P.P., Ballif, B.A., Anjum, R., Gygi, S.P., and Blenis, J. (2004). Tumor-promoting phorbol esters and activated ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Proc Natl Acad Sci USA 101, 13489–13494.
Rush, J., Moritz, A., Lee, K.A., Guo, A., Goss, V.L., Spek, E.J., Zhang, H., Zha, X.M., Polakiewicz, R.D., and Comb, M.J. (2005). Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat Biotechnol 23, 94–101.
Sheldon, M., Rice, D.S., D’Arcangelo, G., Yoneshima, H., Nakajima, K., Mikoshiba, K., Howell, B.W., Cooper, J.A., Goldowitz, D., and Curran, T. (1997). Scrambler and yotari disrupt the disabled gene and produce a reeler-like phenotype in mice. Nature 389, 730–733.
Songyang, Z., and Cantley, L.C. (1995). SH2 domain specificity determination using oriented phosphopeptide library. Methods Enzymol 254, 523–535.
Songyang, Z., Lu, K.P., Kwon, Y.T., Tsai, L.H., Filhol, O., Cochet, C., Brickey, D.A., Soderling, T.R., Bartleson, C., Graves, D.J., et al. (1996). A structural basis for substrate specificities of protein ser/thr kinases: Primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and erk1. Mol Cell Biol 16, 6486–6493.
Swaney, D.L., Wenger, C.D., Thomson, J.A., and Coon, J.J. (2009). Human embryonic stem cell phosphoproteome revealed by electron transfer dissociation tandem mass spectrometry. Proc Natl Acad Sci USA 106, 995–1000.
Thingholm, T.E., Jensen, O.N., and Larsen, M.R. (2009). Analytical strategies for phosphoproteomics. Proteomics 9, 1451–1468.
van der Geer, P., Wiley, S., Gish, G.D., and Pawson, T. (1996). The shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein-protein interactions. Curr Biol 6, 1435–1444.
Villen, J., and Gygi, S.P. (2008). The SCX/IMAC enrichment approach for global phosphorylation analysis by mass spectrometry. Nat Protoc 3, 1630–1638.
Ware, M.L., Fox, J.W., Gonzalez, J.L., Davis, N.M., Lambert de Rouvroit, C., Russo, C.J., Chua, S.C., Jr., Goffinet, A.M., and Walsh, C.A. (1997). Aberrant splicing of a mouse disabled homolog, mdab1, in the scrambler mouse. Neuron 19, 239–249.
Wolters, D.A., Washburn, M.P., and Yates, J.R., 3rd. (2001). An automated multidimensional protein identification technology for shotgun proteomics. Anal Chem 73, 5683–5690.
Yang, G., Li, Q., Ren, S., Lu, X., Fang, L., Zhou, W., Zhang, F., Xu, F., Zhang, Z., Zeng, R., et al. (2009). Proteomic, functional and motif-based analysis of C-terminal src kinase-interacting proteins. Proteomics 9, 4944–4961.
Zhai, B., Villen, J., Beausoleil, S.A., Mintseris, J., and Gygi, S.P. (2008). Phosphoproteome analysis of drosophila melanogaster embryos. J Proteome Res 7, 1675–1682.
Acknowledgements
We thank Lionel Arnaud who was a critical collaborator in the Cooper lab during the development and execution of the methodology to identify pY-Dab1-interacting proteins. We thank Jon Cooper (Fred Hutchinson Cancer Research Center) for support and discussions as well as additional members from his laboratory, particularly Abir Mukherjee, Tara Herrick and Priscilla Kronstad-O’Brien. We thank Steve Gygi (Harvard Medical School) for support and discussions, and members of his laboratory for the same, in particular, Scott Gerber, Wilhelm Haas and Sean Beausoleil. Judit Villén and Xue Li from the Gygi lab played an important role in the initial characterization and development of the SCX-IMAC methods presented here. We thank Steve Elledge (Harvard Medical School) and two members from his laboratory, Shuhei Matsuoka and Chunshui Zhou. Shuhei performed the anti-Akt phospho-substrate peptide IP from tryptic peptides and Chunshui gave helpful insights during the development of the SCX-IMAC methods and provided the tryptic yeast peptides. We thank John Blenis (Harvard Medical School) and two members of his lab, Philippe Roux and Jessie Hanrahan who assisted in the preparation of the cells for the Anti-Akt phoshpho-substrate peptide IP from chymotryptic peptides. We thank John Rush (Cell Signaling Technology) for supplying the AQUA reference peptides. The authors were supported primarily by the following grants during the work presented here and during the writing of this manuscript: NIH 5T32CA09657; NIH HG00041; NSF IOS 1021795; Vermont Genetics Network and NIH/NCRR P20RR16462.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Goswami, T., Ballif, B.A. (2011). Methods for the Isolation of Phosphoproteins and Phosphopeptides for Mass Spectrometry Analysis: Toward Increased Functional Phosphoproteomics. In: Ivanov, A., Lazarev, A. (eds) Sample Preparation in Biological Mass Spectrometry. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-0828-0_29
Download citation
DOI: https://doi.org/10.1007/978-94-007-0828-0_29
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-0758-0
Online ISBN: 978-94-007-0828-0
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)